Composite Graft Use in Abdominal Sacrocolpopexy Reduces Erosion Rates
- Conditions
- Pelvic Organ Prolapse
- Registration Number
- NCT00581412
- Lead Sponsor
- University of California, Irvine
- Brief Summary
This study is to determine whether the use of a composite biologic/synthetic graft during abdominal sacrocolpopexy leads to a lower rate of erosion while maintaining durability.
- Detailed Description
This study will examine the erosion rate of a composite graft that is being used during abdominal sacrocolpopexy. The composite graft is composed of a dual layer of biological and syntheric material. Biological grafts have the advantage of significantly reducing erosion rates, but the longevity of biologic graft is uncertain. On the other hand, synthetic grafts have the advantage in that they are durable, but have higher erosion rates through the vagina and require re-operation in a small percentage of patients. This study will look at whether or not the use of a composite greaft carries the advantages of both types of materials and leads to decreased rates of erosion while maintaining longevity. The cost effectiveness of this new type of graft will also be reviewed since the disavantage of utilizing both the synthetic and biologic graft is that it will increase the cost.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 60
- Patients who underwent abdominal sacrocolpopexy with Drs. Noblett and Lane from 2001 to present
- None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The erosion rates of composite biologic/syntheric grafts and synthetic-only grafts will be compared. To the point of graft erosion after abdominal sacrocolpopexy
- Secondary Outcome Measures
Name Time Method Cost effectiveness will be examined by comparing the price of a composite graft to the cost of re-operation due to erosion of a synthetic-only graft. To the point of graft erosion after abdominal sacrocolpopexy
Trial Locations
- Locations (1)
University of California, Irvine Medical Center
🇺🇸Orange, California, United States